Reddit Posts
I will tell you everything I am invested in, you rate my portfolio. 1 to 5. 5 being awesome....
$ELTP Up Another 10% - Moonshot on Feb 12th Earnings Call?
ELTP - Upcoming Earnings Call and New Prasco Shipments
ELTP ANDA Filing - $5.1 Billion IQVIA Market Value
ELTP -I see so many bad recommendations on here, yet I keep recommending this gem...
ELTP 886% YOY Growth Net Income - Double up SP tomorrow?
886% increase in net income for comparable period of the prior year!!! ELTP is HOT!!!
Penny stocks with promising potential catalysts in 2024: ELTP, BITF, LLAP, and OLB
ELTP...I've been trying to tell you guys for 2 years now...
Why I believe in Elite Pharmaceuticals $ELTP
ELTP UP 39.52% volume 5,317,184 shares traded today!!!
Q4 Stock Predictions: ELTP, OLB, PHX, and GNS are primed to roar into 2024.
ELTP - 93% of money invested in this moon shot
Elite Pharmaceuticals-ELTP New Drug 5.1 Billions IQVIA Market
ELTP - Stock Analysis was spot ON
I'll stop posting ELTP when it stops gaining 20% a day
$ELTP New Financials - Ready to Retire/All-In - Boom time
$ELTP Up 55% from Low - Ready for Breakout?
ELTP Mentioned in Article as Potential Growth Stock
$ELTP Up 30% in last 5 days - 68% in last 6 months
So tell me why companies like this are attacked and abused on the OTC???
Riddle me this - why so abused and attacked on the OTC???
Lets talk about an abused OTC company (ELTP) that is going GLOBAL today!
$ELTP ~ Is this being overlooked or am I missing something?
Mentions
ELTP. Boring but record breaking revenues 5 years in a row. Had a small run but still massively undervalued. Should pop 400% to 1000% when they get bought out or they uplist.
OP, although I found a diamond in the rough and went all in on ELTP, I don’t really play around in the penny stock arena. That being said, this post above is the best response to emulate in my opinion if you decide to risk your money here. I agree with the research on the C Suite. Knowing WHO you are investing in is extremely important and often overlooked. I also agree with the Peter Lynch recommendation. Beat the Street was an influential book for me. Lastly, the other thing I look for is manipulation. If you are good enough at spotting patterns you’ll see them post on boards and which way they are tilting it. That was a big key for me. Finding the low IQ employees of the manipulators with huge egos. I made millions off of their stupidity and hubris. If you see them pushing one way, just make your move in the other direction.
How many people are still holding ELTP?
ELTP They make generic drugs. They make a number of drugs, but their most notable at the moment are generic Adderall, Vyvanse, and Eliquis. Their sales team is unreal - in the first year or so of Adderall production, they captured 16% of the market. Generic Vyvanse has been in production for about 2 quarters, and they're already got 8%-10% of the market captured. The Eliquis filing should be coming soon and represents a huge market as well. This is all in addition to several other drugs I haven't mentioned. It's also worth noting that they just stood up a new manufacturing facility in New Jersey last year. There's been talk of M/A in the last two earnings calls. The CEO is in his sixties and wants out. Conservative valuations are several times the current market cap. If they don't get bought out, most expect a reverse split and uploading to NASDAQ. Frankly, its all noise to me. The company's value is inherent and under appreciated at the moment. It was hyped up a few times last year and got pushed down as the gambler lost interest, but the company continues to grow stronger, and fast. They'e recently became profitable, they have an impressive portfolio of generic both in production and in the pipeline, and most importantly, the management and sales team are consistently kicking ass. I'm still buying.
I promise I did not stalk your profile to see this 😂 I put ELTP in this thread as well
Space X and ELTP. Just did a DD on ELTP hitting $2million revenue per employee. Microcap company putting up numbers better than than Pfizer and Teva? Shit, they have better rev per employee than Amazon, and Netflix.
Maybe like 5x but ELTP. Exceptional revenue, no debt, looking to be acquired. Cons: penny stock, OTC traded. But really look into the fundamentals and how revenue has grown the last two years. It’s a money printer and could get bought out any day this year.
I’m not sure ELTP will ever get over a dollar. It’s very frustrating when they consistently report decent earnings, and then the stock tanks anyway.
$ELTP, they are making drugs in new jersey cleared by the FDA, do all the manufacturing themselves with priority technology for anti addiction , I haven't invested yet because I'm not sure if they are going to scale the business and there is customer push back but their numbers don't lie and company has a PE ratio around 10. OTCMKTS: ELTP
Being a bag holder sucks but people have been saying ELTP will pump or get bought out for over a decade. I had 600k shares at one point from 2005 to 2016. From about 2015 forward, retail continued to drive the assumptions that they would get opioid generic approvals or partnerships to attract buyers. Then it shifted to uplifting rumorsand $5-$10 buyout targets 😂 ELTP has been playing this game for over 20 years. Move on to something with real progress.
ELTP. Strong financials but still in penny territory. Multiple avenues for growth. It is a legitimate company.
It’s ELTP and it’s not even close. $2 million revenue per employee, 5 straight years of record breaking earnings, Oxy generic on the horizon, anti abuse technology, and the company hired an M&A firm 8 months ago. I’ve been calling this since about 3 cents. If you can’t see this one, you are actually blind.
Check out ELTP earnings are just insane lately
Waiting for ELTP the swing back upward. It’s been floating around $.40 for too long now. Anywhere but up
With options, being early is the same as being wrong my dude, please just trust your instincts and stick to shares. Take it from me, I bought AMD and NVDA in 2014 and made so much that I have a six figure gambling account for options now. Idk if you can get it in WEBULL but I’d load up on an OTC stock called ELTP, crazy good financials and a possible buyout in the near future. But again it’s a set it and forget it play. Wising you well, shake it off and grind it back.
Castellum (ctm) and Elite Pharmaceuticals (ELTP)
ELTP - never seen a penny stock which such strong balance sheet and high growth. One of those stocks people 5 years later wish they could’ve bought for cents.
ELTP Revenue fiscal year 2021: 25 millions Revenue fiscal year 2022: 32 millions Revenue fiscal year 2023: 56 millions Revenue fiscal year 2024: 84 millions Price per share: 0,30-0,40$ Revenue fiscal year 2025: 150 millions (projected, they reached 100 millions in December 2025 and the fiscal year end in March 2026) Current share price: 0,39$ Current debt: 3 million Major shareholder: Nasrat Hakim, CEO Working capital has also increased over the years and is now around 80 million. Revenues are nearly doubling every year. The company is looking for a buyer, and if you listen to the November 2025 conference call, the CEO said: "I gave my team until the end of the year to find a buyer, and it seems that it is possible." Also, look at the share price, it stayed the same even when the revenues nearly doubled, the company is clearly undervalued. In the last conference call, the CEO didn’t disclose anything particularly relevant—only that they are waiting to file the NDA for a $19 billion drug and that starting in Q1 and Q2 2026, they will begin selling Ropinirole and Methadone. The CEO does not want to do a reverse split to uplist to NASDAQ because he is the major shareholder and does not want a reverse split. He prefers to sell the company instead. So, as you can see, the company appears solid: growing revenues, low debt, and new drugs in the pipeline. This is not a pump and dump; it’s a solid company. That’s why I keep buying shares.
ELTP (Elite Pharmaceutical) - financials from the past year are below, but they are also pursuing M&A and could get news at any point. Financial Breakdown February 2026 Earnings Summary 3rd Quarter FY 2026 (ending 12/31/25) Revenue: 31.6 million (increase of 17.2 million or 120% from the comparable quarter in the previous year) This does not include 6.2 million in finished goods that were not shipped due to the timing of holiday shipments. Including this amount would place the quarter at nearly 38 million. The CFO discussed this on the recent conference call). Adding this, would have put us around $38 million for the quarter, and roughly a $2 million increase from previous quarter. Matches CEO’s comments that margins stabilized. Even without this number included into the financials…here are the results of the quarter: Income from operations: 9 million (increase of 7.9 million or 721% year over year) Cash: 21 million Inventory: 25 million Accounts receivable: almost 49 million November 2025 Earnings Summary 2nd Quarter FY 2026 (ending 9/30/25) Revenue: 36.3 million (increase of 17.4 million or 92% from the comparable quarter in the previous year) The decrease of roughly 4 million from the prior quarter was due to one-time stocking fees required when using wholesale distribution. Leadership explained this as part of the natural progression of generic drugs, where margins are impacted during the shift from brand to generic and increased competition. Margins were stated to have stabilized. Using wholesale distribution also helps us increase volume. Income from operations: 8.2 million (increase of 4.7 million or 136%) Cash: 26 million Inventory: 18 million Accounts receivable: almost 41 million August 2025 Earnings Summary 1st Quarter FY 2026 (ending 6/30/25) Revenue: 40.2 million (increase of 21 million or 114%) Managements explained that when you hit generic market, initial margins are higher and that it will stabilize and to expect a slight dip for next quarter) Operating profits: 22 million (increase of 17.8 million or 462%) Cash: 22 million (up 11 million from previous quarter) Inventory: 19 million Accounts receivable: 36 million June 2025 Earnings Summary Fiscal Year 2025 – Full Year Results (4/1/24 – 3/31/25) Full-year revenue: 84 million (increase of 27.4 million from previous year, a 48% increase) Operating profits: 19.6 million (increase of 8.8 million or 81% from previous year) Cash: 11 million Inventory: 16 million Accounts receivable: 29 million February 2025 Earnings Summary 3rd Quarter FY 2025 (ending 12/31/24) Revenue: 14.4 million Operating profits: 1.1 million
$ELTP - generic pharma - ROCK SOLID fundamentals , low debt, blockbuster pipeline and USA facilities to avoid tariffs Downside includes moderately high outstanding shares and OTC market (for now).
Take a look at ELTP. When FY ends (3/31), they will be near double revenue. Almost 3:1 asset to liabilities ratio. in talks to potential merge or be acquired. Next 3 months could be very interesting
Maybe look into ELTP.... They are cash positive, little debt, increasing yoy by large margins.....and trade at a lower multiple than other pharma. The play at the moment is they are trying to get bought out (M&A)......but that hasn't happened up till this point yet. As a result, people that jumped in- in last year are starting to get impatient and move on. The company however in the mean time, continues to post fantastic numbers..... If they cant find a buyer through M&A, then the plan is to up list to NASDAQ. Up listing with the current numbers would result in quite a leap in share price in theory.....assuming Elite was valued the same way, and in similar multiples to industry peers. I personally think this will pay off quite well - although I cannot predict exactly when. It happens to be sitting at a fairly low point right now too (.38-.40) Just my 2c, dont think it make you rich overnight - but I do think its got really great numbers, especially for a OTC and will pay off in time.
Honest question here, what is a fair price for ELTP right now?
I really enjoy your perspective on this, well thought out and presented in an enjoyable read! I have been in ELTP for 15 years, with 7 figure share count as well. I think we close to payday.
That was from 3 weeks ago when I sold ELTP until now, all while metals have been trading mostly sideways. Imagine having sold ELTP 6 months ago (it is now down 35% since then) and moving into, say, FCX (up 54%) or ANY other metals company. Hell most of my metal tickers are up over 200% on the 6months, 2 are up over 900%. It doesn’t have to be metals. What about space sector? ASTS, RKLB both are doing 70+% Again, the opportunity cost is just too high. Yes, money was made with ELTP if you got in early enough; but this is trading man. If you’re going to just sit park your money and pray do it in VOO or any other ETF (which have ALL dramatically outpaced ELTP) Your money is dying in ELTP and you are desperately trying to convince these folks it’s a gem. Beware folks. This isn’t a team sport.
I wouldn’t come to WSBs for advice… But since you did, I’d load up on ELTP and pray for a buyout in March. Pretty sure lotto options or a penny stock pump would be your only other chances.
ELTP - one billion shares outstanding. Auggh.
GPUS and ELTP. Let this be the 1 time ELTP runs after another fantastic earnings report.
ELTP just reported a 200% increase in earning YOY. Even more interesting is the $400k in legal fees despite no pending litigation. Buyout is near.
if you like PSTV, then you'll LOVE ELTP. Buy today before earnings call tomorrow. Trust me bro. nfa
Don't need the list this month. All my bio powder is in the ELTP chamber
Does 99.24% of portfolio count as all in? I have $2.6 million on ELTP. Earning report tomorrow. Earnings call Wednesday morning. Buyout will happen some time this year. CEO stated his goal was to have company sold prior to August.
How many conference calls does somebody need to “read between the lines” before a buyout happens. If you say the same thing every conference call you might be right someday but stop this nonsense with ELTP
Look at what the CEO of ELTP said in the last CC Not wolf, but the CEO
You missed ELTP, buyout immenent
I hope OP responds to you as I’m curious as well. Though, as someone noted below on a similar comment, is that all you really have to say about this post? I’ve seen a lot of your DD on ELTP and I’d be curious to read your genuine take on SLS.
I'm gonna say this post is HIGHLY suspicious. You did 1000 hours of research on this stock? You a full time trader or do you have another job? If the former, you have time to trade stocks and do 6 months of 40 hours of research? If another job, you have 6 months of time at 40 hours a week to do this research? I find that incredibly hard to believe. What's harder to believe is that you ALSO did exactly 1000 hours of research on CNC stock 10 days ago? One full year of research on 2 stocks. And you only have 2 total posts on your account? Sus af. I have done more research on ELTP that anyone alive that I know (there are also a few other very talented investors who do great research as well and provide great info). I've researched ELTP since 2017 and didn't invest in is until 2021 and yeah I probably have 1000 hours of research....over a NINE year period. My account is also flooded with original DD posts on ELTP and response posts. I'm not saying whether this is a good stock or not, because I haven't researched it, but I'm already suspicious of the quality of the DD if I spot a likely lie like that in the first paragraph.
I was a Lannett investor at the time, the one amusing thing to me is that Lannett had one drug (levothyroxine) that alone had more revenue than the entirety of ELTP ($245m vs $120m). Lannett losing the contract for distribution of levo was the end for them, none of the other drugs they had could cover their debts. Levo by itself was close to %40 of Lannett's revenues at the time. ELTP certainly have better financial control and as far as I'm aware they are not dependent on one product.
Barring future catastrophic failure ELTP is in such a good position right now. You either get bought out within a year or they will start uplisting. Even if uplisting is the route it is such a strong company. It would probably take a hit based on sentiment alone but how could it not recover, it’s a damn money printing operation.
Huh? I don’t even get what the LARP comment is referencing? I’m larping about investments? You think I’m “trading” penny stocks and trying to get rich quick because you did a cursory glance at my account and didn’t realize I’ve been researching that stock for 8 years and realized it was an absolute gem of a find? ELTP isn’t just some penny stock. I’m up over 1200% because I saw a cash flowing OTC company that was massively undervalued. This wasn’t the insult you thought it was gonna be. Congrats on bragging about not being able to do your own analysis and find things that other people arrogantly brush over.
MOBX...defense communications for aviation like F35 used by US and allies. Drip in, too cheap imo. CTM...oldie and goodie...sideways..shame ELTP...sad to see this sideways 😞...actually makes a profit but no love...
MOBX...defense communications for aviation like F35 used by US and allies. CTM...oldie and goodie...sideways..shame ELTP...sad to see this sideways 😞...actually makes a profit but no love...
ELTP baffles me. Great Financials. Always profitable. Just keeps dropping. Which is fine, I'll keep buying.
MOBX...defense communications for aviation like F35 used by US and allies. CTM...oldie and goodie...sideways..shame ELTP...sad to see this sideways 😞...actually makes a profit but no love... Becareful with BNAI....sill more room to fall.
MOBX...defense communications CTM...oldie and goodie...sideways..shame ELTP...sad to see this sideways 😞...actually makes a profit but no love... Becareful with BNAI....it will fall back to earth.
MOBX...defense communications CTM...oldie and goodie...sideways..shame ELTP...sad to see this sideways 😞...actually makes a profit but no love...
I held ELTP from 0.25 to 0.50 and left cause it was doing nothing for a long time. Glad I put my money into other stocks which actually moved instead of staying in the same price range. The CEO has been talking about uplisting and a buyout for a while and nothing happened either. Maybe another year or maybe years away.
Use fidelity or Schwab for OTC stock, I use it for ELTP
As much as I am positive towards this stock and have been for a while (in parts also thanks to your continuous digging, Wolvshammy), I find that this post could use some slight nuances .. As thinly traded as ELTP is, any attempt from an Executive VP to sell 3.5 million shares would make the share price plummet. In addition, exercising a stock option with a strike price at 0.03USD ultimately just confirms that Doug believes that ELTP is worth more than that - 0.03USD. With that said, my anticipated buyout price is in the 0.9-1.3USD range.
Two pennstocks that actually make money: CTM ELTP
Oldie but Goodies CTM ELTP Both actually make money.
Two pennystocks that are actually profitable: CTM ELTP Non-penny that's still cheap: RYCEY...with Meta and other big tech getting in to nuclear to power their data centers...Rolls Royce Aerospace does SMRs.
Oldie but Goodies CTM ELTP Both actually make money.
ELTP just started running on no news.... Buyout imminent?
I don’t look at graphs when looking for something that I’m hypothesizing could trigger in the future. Also, I don’t chart pennies, but maybe that strategy works. Just doesn’t seem like it would because charts and history seem more useful to a stable ship. ELTP seems like one of the safest pennies I’ve ever seen and the charts make no sense on that one.
The position I posted is based off of a new shiny product. Yes, it’s an old company that has missed on everything except one hit in the early 80s. I don’t think this is a great company (could be if they made a strong of good decisions spearheaded by good leadership), but that’s not what my thesis here is. I think San Fran is a cesspool, but at some point, if the price gets low enough, I’d consider buying if I saw potential for a blip. If this company hits an accidental triple with a single good design then I’ll take the quick gains on a 100% jump in revenue. It’s conditional logic and you are only attacking the company. If you want to attack the condition itself, that would be the more logical approach. The only otc stock I’m long on is ELTP. Let’s not act like this forum is where you usually go to look at strong fundamentals. I’ve only ever found one of those.
I wouldn't usually, but I'm holding ELTP until they get bought out.
ELTP - Elite Pharmaceuticals Strong fundamentals, high revenue growth, low debt, the CEO is looking to sell the company soon, they already completed the evaluation phase
I’m in on Canadian. Qessf and asrmf. ELTP also
ELTP is around $.50. Good fundamentals and actively seeking to sell the company.
ELTP is a good one, they're looking to sell the company right now, have really solid revenue, and still have modes for growth if a sale doesn't go through before June. There's tons of really good dd posts for it here on reddit
ELTP - buyout is imminent. Fundamentals are rock solid. It’s not sexy…it’s just a boring little stock run by a great executive team. I’ll take my free 3x to 8x at buyout and go redeploy afterwards. I invested $1 million in it.
I got out of ELTP a few months ago. I actually thought the new factory would be a big positive on stock price. They now have excess manufacturing capacity which should ease the growth of new products. At this point I can't see them successfully uplisting or even if that would be advantageous at the moment. The speculated buyout has yet to happen and frankly I'd be shocked if they got enough to make share holders happy. Frankly they are profitable now and I think the thing for them to do right now is to move the business along. Basically build the business up. So I'm not sure what has driven the price down, I tried a grok search to determine investment potential and buyout possibilities. Grok wasn't really helpful in putting a pin on what has driven the price down after a good quarter. Being a buyout target is a big question mark too. I'd be tempted to get back in because I really expected by about this time the stock would be going uphill not downhill.
Stuff I see here is mostly gambling. I’ve made a few chunks of money here and there, but most of my money on penny stocks was made on ELTP, but I heard about it offline and did research before going all in. That’s a buy and hold strategy though and it looks like the buyout is imminent. After that, the majority of my stock money would go back towards mid/large/mega caps and my other investments/businesses. The problem here is the average poster isn’t providing any good analysis and the people that do provide good analysis don’t catch as much attention, so good value gambles/plays are something you have to be very careful with and do the deep dipping yourself.
ELTP. Company should get bought out soon. Record breaking revs, new drugs approved, unsolicited buyer visited facility.
Would you rather… invest in ELTP or HGRAF? I’m in both and want to add to my position. I’m thinking long for Hgraf and just trying to make a few bucks on ELTP. I’m underwater in both at present, but believe each will recover. I have a daughter’s wedding in July so a couple extra bucks from ELTP sounds good, but I like the long term outlook of HGRAF.
ELTP actively working on buyout. CEO said he wants deal done by end of year. Only question is calendar or fiscal year. So 2 weeks or 3 months?
ELTP is aiming at getting bought out, same for MIR
CTM , ELTP are legit
ELTP will make you rich in a few weeks from now
1 million on ELTP? SURE BUDDY
ELTP - I put $1 million in to it. It’s one of the few actual legitimate small cap companies with real financials, growing revenue, and an unsolicited visit from a potential buyer. CEO hired M&A firm to work towards the goal of selling the company. This isn’t even an if. The only debate is when. I’ve done years of research on it and have posted valuations. I haven’t posted as much on it lately because I was busy selling a company and tbh, I feel like the people who wanted to hop on the train after all my DD are probably already on the train with me.
If even half of what he’s hinting at turns out true, ELTP could explode from these levels because the setup already has that “something big is coming” energy. Hard not to get excited watching a story build like this.
Of the reasons I can say: 1. Israeli company (ELTP just entered that market) 2. Known for being willing to make a bet on a merger. 3. Ego - the desire to right perceptions of past mismanaged moves. 4. Market size of company is right. 5. Near perfect fit as far as market types. 6. Familiarity- the parties know each other. 7. Politics- US and Israeli 8. Competitive addition 9. Good defensive play and offensive play. 10. Timing. Reasons I can’t say: 1. I can’t say.
Been listening to Nasrat speak in ELTP CC's for over a decade now. He doesn't necessarily speaks in code, but for those that haven't listened to him often will usually have a negative take-away from his presentations, (where the opposite is being conveyed by him). ELTP had a fantastic quarter..., and yet Nasrat's words were the most *controlled* within a CC that I can recall. We are obviously speculating right now, but that entire room felt like a cold shower - right after winning the Superbowl. They are being very cautious right now, which you have to ask yourself the *million dollar question*..., why?
ELTP. Waiting anxiously for Nasdaq uplist. They just recently received FDA approval
ELTP for some reason has some momentum up with a bit more volume.
ELTP took a dump at open, . Good earnings reported friday AH and they have a conference call in about an hour. Consolidated revenues for the three-month period ending September 30, 2025, were $36.3 million, an increase of $17.4 million or approximately 92% as compared to the comparable period of the prior fiscal year. Income from operations was $8.2 million, an increase of $4.7 million or approximately 136%, as compared to the comparable period of the prior fiscal year. maybe a rally during or after the conference call. worth keeping an eye on.
To be blunt, you need a financial adviser. I think you don’t know what makes a stock good because you don’t want to take the time to learn. You want shortcuts. That always leads to loss of principle. You could click my profile and type “ELTP” and you’d see more analysis on this stock done by me than by anyone else on Reddit and you couldn’t even take the 5 seconds to do that. That means you don’t really want to research. If you think my answer is dickish instead of thoughtful and considerate as to what you really need to hear to grow as a person, then you should hire a financial adviser and a therapist.
I bought at 0.25 and sold at 0.55. Was tired of waiting and seeing so many other stocks rocket up and ELTP just slowly rising. Maybe when it gets out of OTC or has a buy out then payday will finally come. Otherwise just gonna be the same until then.
ELTP earnings. Get in before it’s too late. You can guarantee yourself 10-20% as we soar into 70’s Monday. 
For what it’s worth, of all the small penny bets I’m holding, I’m most confident in ELTP, DFLI, and XTRAF (in that order).